FDA chief nominee Makary pledges to 'review' cancellation of vaccine panel meeting
FDA nominee Marty Makary pledges to review the cancellation of a key flu vaccine meeting, addressing concerns over ...
Novavax (NVAX) Predicts Profitability by 2027 Despite Recent Stock Drop
Novavax (NVAX) has recently seen a decrease in stock value, dropping after announcing Q4 results that missed revenue expectations. The company ...
CNET18h
How the 3 New COVID Vaccines Change the Way You Pay
Now that Novavax has been added to the revamped COVID vaccines, you'll want to make sure to check on the changes to cost and more.
Novavax Inc. stock underperforms Tuesday when compared to competitors
Shares of Novavax Inc. NVAX shed 2.41% to $7.68 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.35% to 18,285.16 ...
Novavax Q4 Earnings Review: Long-Term Downsizing Plan Suggests Sell Rating
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
Stocktwits on MSN6d
Novavax Lands Wall Street 'Buy' Rating After Q4 Results, Retail Bulls Eye More Upside On Sanofi Partnership
Novavax Inc. (NVAX) shares climbed over 1% in after-hours trading Thursday as the vaccine maker's revenue outlook and ...